FindTrial
Sign In

Comparative, double arm, non-randomized study for Androgenetic Alopecia

A study of effect of stromal vascular fraction versus platelet rich plasma in treatment of Androgenetic Alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042206
Enrollment
10
Registered
2022-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: STROMAL VASCULAR FRACTION: Hair density assessed by trichoscan will be analysed and the results will be assessed at 6 Week and 12 weeks post-procedure Intervention2: NA: NA Control Inte

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and female patients with androgenic alopecia 2.Age 18 years and above 3.Norwood Hamilton Grade II to VI 4.Ludwig’s grade I to III 5.Active hair loss in the past 6 months

Exclusion criteria

Exclusion criteria: 1.Patients on any treatment in the last 6 months 2.Pregnancy and lactation 3.Bleeding tendency or anticoagulant therapy 4.History of keloid formation 5.Malignancy or immunosuppression 6.Active systemic or scalp infection

Design outcomes

Primary

MeasureTime frame
To know the efficacy of stromal vascular fraction in Androgenic Alopecia to understand the safety profile of the procedureTimepoint: After 3 months—

Secondary

MeasureTime frame
Clinical photographs, trichoscan, Physician and patient global assessment will be done at base line, 6 weeks and 12 weeks to analyse the outcome.Timepoint: After 3 months—

Countries

India

Contacts

Public ContactDr Madura C

CUTIS Academy of Cutaneous Sciences

maduradr@gmail.com9632741998

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026